EndoS
/ Hansa Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 26, 2026
Imlifidase and EndoS enables haploidentical bone marrow engraftment in sensitized mice under reduced intensity conditioning.
(PubMed, Transplant Cell Ther)
- "Enzymatic inactivation of DSA facilitates donor hematopoietic stem cell engraftment in allo-sensitized haploidentical recipients in a reduced intensity conditioning protocol and induces tolerance of donor tissue grafts."
Journal • Preclinical • Bone Marrow Transplantation • Immunology • Transplantation
June 25, 2018
Diabetic Gastroparesis: Principles and Current Trends in Management.
(PubMed, Diabetes Ther)
- "...Selected medication-refractory patients with DGp may benefit from gastric neuromodulation, and some from surgical interventions including pyloric therapies that can also be done endoscopically. As is true of any of the diabetic complications, prevention of DGp by early and optimal glycemic control is more cost-effective. Hansa Medcell, India."
Journal • Review • Biosimilar • CNS Disorders • Diabetes • Gene Therapies • Genetic Disorders • Metabolic Disorders • Pain
1 to 2
Of
2
Go to page
1